Cargando…
Facilitation of Drug Transport across the Blood–Brain Barrier with Ultrasound and Microbubbles
Medical treatment options for central nervous system (CNS) diseases are limited due to the inability of most therapeutic agents to penetrate the blood–brain barrier (BBB). Although a variety of approaches have been investigated to open the BBB for facilitation of drug delivery, none has achieved cli...
Autor principal: | Meairs, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588200/ https://www.ncbi.nlm.nih.gov/pubmed/26404357 http://dx.doi.org/10.3390/pharmaceutics7030275 |
Ejemplares similares
-
Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
por: Wang, Xiang, et al.
Publicado: (2014) -
Blood-brain barrier disruption induced by diagnostic ultrasound combined with microbubbles in mice
por: Zhao, Bingxia, et al.
Publicado: (2017) -
Microbubble drug conjugate and focused ultrasound blood brain barrier delivery of AAV-2 SIRT-3
por: Trinh, Dennison, et al.
Publicado: (2022) -
State-of-the-art of microbubble-assisted blood-brain barrier disruption
por: Song, Kang-Ho, et al.
Publicado: (2018) -
Focused Ultrasound and Microbubbles-Mediated Drug Delivery to Brain Tumor
por: Wu, Sheng-Kai, et al.
Publicado: (2020)